Workday
- Market cap
- 44.41B
- P/E (TTM)i
- 37.53
- P/Bi
- 6.87
- EPSi
- 2.59
- Div yieldi
- 0.00%
- 52W posi
- 54%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 89.75% +0.07pp
- Institutions
- 1,179 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-09-23
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 12 buys · 38 sells
| Name | Role | Stake |
|---|---|---|
| David Duffield | Co-Founder & CEO Emeritus | 14.93% |
| Aneel Bhusri | Co-Founder, Co-CEO & Chairman of the Board | 3.56% |
| Carl Eschenbach | Co-Chief Executive Officer | 0.14% |
| George Still | Vice Chairman & Lead Independent Director | 0.05% |
| Chih-Yuan Yang | Independent Director | 0.04% |
| Douglas Robinson | Co-President | 0.04% |
| Zane Rowe | Chief Financial Officer | 0.03% |
| Thomas Bogan | Director | 0.02% |
| Richard Sauer | Chief Legal Officer, Head of Corporate Affairs & Corporate Secretary | 0.02% |
| Michael McNamara | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-04 | Robert Enslin | President & Chief Commercial Officer | Intent to Sell (Form 144) | -5,374 | $186.00 |
| 2026-09-30 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -98,446 | $183.86–194.77 |
| 2026-09-27 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -98,971 | $182.67–190.60 |
| 2026-09-22 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -99,613 | $188.92–193.62 |
| 2026-09-17 | David Duffield | Co-Founder & CEO Emeritus | Other Disposition | -94,089 | -- |
| 2026-09-17 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -94,089 | $194.04–195.73 |
| 2026-09-14 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -96,545 | $190.71–194.39 |
| 2026-09-09 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -100,780 | $184.33–187.75 |
| 2026-09-04 | Zane Rowe | Chief Financial Officer | Sale to Issuer | -2,808 | $195.79 |
| 2026-09-04 | Robert Enslin | President & Chief Commercial Officer | Sale to Issuer | -2,228 | $195.79 |
| 2026-09-04 | Gerrit Kazmaier | President of Product and Technology | Sale to Issuer | -3,369 | $195.79 |
| 2026-09-03 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -90,615 | $195.81–204.05 |
| 2026-08-31 | David Duffield | Co-Founder & CEO Emeritus | Other Disposition | -94,961 | -- |
| 2026-08-31 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -94,961 | $197.38–204.92 |
| 2026-07-09 | Mark Garfield | Chief Accounting Officer | Open Market Disposition | -918 | $142.19 |
| 2026-07-08 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -107,500 | $130.63–138.98 |
| 2026-07-06 | Zane Rowe | Chief Financial Officer | Automatic Disposition | -6,000 | $143.06–144.93 |
| 2026-07-06 | Gerrit Kazmaier | President of Product and Technology | Automatic Disposition | -2,728 | $142.96–144.96 |
| 2026-07-05 | David Duffield | Co-Founder & CEO Emeritus | Derivative Exercise and Sale | -107,500 | $129.82–138.30 |
| 2026-07-05 | Robert Enslin | President & Chief Commercial Officer | Intent to Sell (Form 144) | -5,374 | $132.99 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:36:08 · For reference only, not investment advice and not tailored to your situation.